<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">483</article-id><article-id pub-id-type="doi">10.15690/vramn.v70.i4.1403</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PHYSIOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ФИЗИОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Parametabolism as Non-Specific Modifier of Supramolecular Interactions in Living Systems</article-title><trans-title-group xml:lang="ru"><trans-title>Параметаболизм как неспецифический модификатор супрамолекулярных взаимодействий в живых системах</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Козлов</surname><given-names>Вадим Авенирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cheboksary</p></bio><bio xml:lang="ru"><p>доктор биологических наук, кандидат медицинских наук, профессор кафедры фармакологии, клинической фармакологии и биохимии,</p><p>428015, Чувашская Республика, Чебоксары, Московский пр-т, д. 45</p></bio><email>pooh12@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sapozhnikov</surname><given-names>S. P.</given-names></name><name xml:lang="ru"><surname>Сапожников</surname><given-names>Сергей Павлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cheboksary</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, заведующий кафедрой медицинской биологии с курсом микробиологии и вирусологии,</p><p>428015, Чувашская Республика, Чебоксары, Московский пр-т, д. 45</p></bio><email>adaptagon@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sheptuhina</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Шептухина</surname><given-names>Алена Игоревна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cheboksary</p></bio><bio xml:lang="ru"><p>студентка 5-го курса медицинского факультета </p><p>428015, Чувашская Республика, Чебоксары, Московский пр-т, д. 45</p></bio><email>priffetik@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golenkov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Голенков</surname><given-names>Андрей Васильевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cheboksary</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующий кафедрой психиатрии, медицинской психологии и неврологии,</p><p>428015, Чувашская Республика, Чебоксары, Московский пр-т, д. 45</p></bio><email>golenkova@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.N. Ul’ianov Chuvash State University</institution></aff><aff><institution xml:lang="ru">ЧувГУ им. И.Н. Ульянова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-09-29" publication-format="electronic"><day>29</day><month>09</month><year>2015</year></pub-date><volume>70</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>397</fpage><lpage>402</lpage><history><date date-type="received" iso-8601-date="2015-09-28"><day>28</day><month>09</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-09-28"><day>28</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Издательство "Педиатръ"</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2016-09-29"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/483">https://vestnikramn.spr-journal.ru/jour/article/view/483</self-uri><abstract xml:lang="en"><p>As it became known recently, in addition to the enzyme (enzymes and/or ribozymes) in living organisms occur a large number of ordinary chemical reactions without the participation of biological catalysts. These reactions are distinguished by low speed and, as a rule, the irreversibility. For example, along with diabetes mellitus, glycation and fructosilation of proteins are observed resulted in posttranslational modification with the low- or nonfunctioning protein formation which is poorly exposed to enzymatic proteolysis and therefore accumulates in the body. In addition, the known processes such as the nonenzymatic carbomoylation, pyridoxylation and thiamiation proteins. There is a reasonable basis to believe that alcoholic injury also realized through parametabolic secondary metabolites synthesis such as acetaldehyde. At the same time, the progress in supramolecular chemistry proves that in biological objects there is another large group of parametabolic reactions caused by the formation of supramolecular complexes. Obviously, known parameterizes interactions can modify the formation of supramolecular complexes in living objects. These processes are of considerable interest for fundamental biology and fundamental and practical medicine, but they remain unexplored due to a lack of awareness of a wide range of researchers.</p></abstract><trans-abstract xml:lang="ru"><p>Относительно недавно стало известно, что помимо ферментативных (с участием энзимов и/или рибозимов) в живых организмах протекает большое число обычных химических реакций без участия биологических катализаторов. Эти реакции отличает низкая скорость и, как правило, необратимость. Так, к примеру, при сахарном диабете наблюдаются гликирование и фруктозилирование белков, приводящие к их пострансляционной модификации с образованием низко- или афункционального белка, плохо подвергающегося ферментативному протеолизу и по этой причине накапливающегося в организме. Кроме того, известно о таких процессах, как неферментативное карбамоилирование, пиридоксилирование и тиаминирование белков. Существуют достаточные основания считать, что алкогольная интоксикация также реализуется за счет параметаболического образования вторичных метаболитов ацетальдегида. В то же время в связи с успехами развития супрамолекулярной химии становится очевидным, что в биологических объектах существует еще одна большая группа параметаболических реакций, обусловленная образованием супрамолекулярных комплексов. Очевидно, что известные параметаболические взаимодействия могут модифицировать образование супрамолекулярных комплексов в живых объектах. Эти процессы представляют значительный интерес для фундаментальной биологии, а также для фундаментальной и практической медицины, однако в связи с отсутствием достаточной осведомленности широкого круга исследователей остаются неизученными</p></trans-abstract><kwd-group xml:lang="en"><kwd>parametabolism</kwd><kwd>acetaldehyde</kwd><kwd>amyloid</kwd><kwd>ketoacid</kwd><kwd>urea</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>параметаболизм</kwd><kwd>ацетальдегид</kwd><kwd>амилоид</kwd><kwd>кетокислоты</kwd><kwd>мочевина</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Lehn J.-M. Supramolecular Chemistry-Scope and Perspectives: Molecules, Supermolecules, and Molecular Devices (Nobel Lecture). Angew. Chem. Int. Ed. Engl. 1990; 29 (11): 1304–1319. Doi:10.1002/anie.199013041.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Pennisi E. Inching toward the 3D genome. Science. 2015; 347 (6217): 10. Doi: 10.1126/science.347.6217.10.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Lehn J.-M. Supramolecular chemistry: Concepts and perspectives. VCH: Weinheim. 1995. P 1–6.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Hammouda A.M., Mady G.E. Correction formula for carbamylated haemoglobin in diabetic uraemic patients. Ann. Clin. Biochem. 2001; 38 (Pt. 2): 115–119.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Maillard L.C. Genese des matieres proteiques et des matières humiques: action de la glycérine et des sucres sur les acides amines. P aris: Masson. 1913. 220 p.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Wrodnigg T.M., Eder B. The Amadori and Heyns Rearrangements: Landmarks in the History of Carbohydrate Chemistry or Unrecognized Synthetic Opportunities? Topics Curr. Chem. 2001; 215: 115–152.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Ahmed N., Babaei-Jadidi R., Howell S.K., Beisswenger P.J., Thornalley P.J. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia. 2005; 48: 1590–1603.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., Thornalley P.J. Prevention of incipient diabetic nephropathy by high dose thiamine and benfotiamine. Diabetes. 2003; 52: 2110–2120.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Ansari N.A., Rashid H. The Nonenzymatic glycation of proteins: from diabetes to cancer. Biomed. Chem. (Russia). 2010; 56 (2): 168–178.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. The scientific basis for healthy aging and antiaging processes. A. Sharman, J. Jumadilovper (eds.). New York: Mary Ann Liebert, Inc. 2011. 184 p.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Koenig B.S., Peterson C.M., Kilo C., Cerami A., Williamson J.R. Hemoglobin A1C as an indicator of the degree of glucose intolerance in diabetes. Diabetes. 1976; 25: 230–232.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Sell D.R., Lane M.A., Johnson W.A., Masoro E.J., Mock O.B., Reiser K.M., Fogarty J.F., Cutler R.G., Ingram D.K., Roth G.S., Monnier V.M. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 485–490.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Pat. No.: 2203087 USA, IPC A61K C07K Method and device for obtaining cell free substitute for red blood cells. R.E. Dewoskin, M.D. Doubleday (eds.). Applicant and patentee of the Northfield Laboratories. NY. Appl. 27.03.1997, publ. 20.08.2000.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Mabuchi R., Kurita A., Miyoshi N., Yokoyama A., Furuta T., Goda T., Suwa Y., Kan T., Amagai T., Ohshima H. Analysis of N(e) ethyl lysine in human plasma proteins by gas chromatography</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>negative ion chemical ionization/mass spectrometry as a biomarker for exposure to acetaldehyde and alcohol. Alcohol Clin. Exp. Res. 2012; 36 (6): 1013–1020.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>15. Jang M.H., Piao X.L, Kim H.Y., Cho E.J., Baek S.H., Kwon S.W., Park J.H. Resveratrol oligomers from Vitis amurensis attenuate beta amyloid induced oxidative stress in PC12 cells. Biol. Pharm. Bull. 2007; 30: 1130–1134.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>16. Savaskan E., Olivieri G., Meier F., Seifritz E., Wirz-Justice A., Muller-Spahn F. Red wine ingredient resveratrol protects from beta amyloid neurotoxicity. Gerontology. 2003; 49: 380–383.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>17. Kozlov V.A., Sapozhnikov S.P. Golenkov A.C., Sheptuhina A.I. The comparative analysis of various amyloid models. Annals of the Russian Academy of Medical Sciences. 2015. №1. С. 5–11.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>18. Kozlov V.A., Golenkov A.C., Sapozhnikov S.P. Minor impurities consumption of alcohol as the cause of death of the population of Russia. Narcology (Russia). 2013; 9: 66–70.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>19. Yakovleva L.M., Sapozhnikov S.P. Structural changes of the small intestine and absorption of chemical elements in experimental alcoholic intoxication. Narcology (Russia). 2012; 11: 9 (129): 44–47.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>20. Semba R.D., Ferrucci L., Bartali B., Urpí-Sarda M., Zamora-Ros R., Sun K., Cherubini A., Bandinelli S., Andres-Lacueva C. Resveratrol levels and all cause mortality in older community dwelling adults. JAMA Intern. Med. 2014; 174 (7): 1077–1084.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>21. Kozlov V.A., Novikov K.V., Mokeeva T.G., Kuz’mina S.A. Cyclocondensation of oxoacids with urea. Russian J. General Chem. 2013; 83 (7): 1467–1468.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>22. Degli S., Nicholson D. An Introduction to Metabolic Pathways. New York. 1970. 310 p.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>23. Kozlovskaya L.C., Rameev V.V., Sarkisova I.A. Amyloidosis in the elderly. Clin. Med.: Scientific-Pract. J. 2005; 83 (6): 12–20.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>24. Leslie M. Searching for the secrets of the super old. Science. 2008; 321: 1764–1765.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>25. Chiu K., So K.F., Chuen-Chung Ch. R. Progressive Neurodegeneration of Retina in Alzheimer’s disease Are β-Amyloid Peptide and Tau New Pathological Factors in Glaucoma? Glaucoma. Basic &amp; Clin. Aspects. 2013. URL: http://www.intechopen.com/books/glaucoma-basic-and-clinical-aspects/progressive-neurodegeneration-of-retina-in-alzheimer-s-disease-are-amyloid-peptideand-tau-new-patho (available: 10.04.2015).</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>26. Vattemi G., Nogalska A., King Engel W., D’Agostino C., Checler F., Askanas V. Amyloid beta 42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion body myositis. Acta Neuropathol. 2009; 117 (5): 569–574.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>27. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., Mathis C.A., Elmaleh D.R., Shoup T., Fischman A.J., Hyman B.T., Growdon J.H., Johnson K.A. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008; 71 (12): 903–910.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>28. Head E., Lott I.T. Down syndrome and beta-amyloid deposition. Curr. Opin. Neurol. 2004; 17 (2): 95–100.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>29. Irvine G.B., El-Agnaf O.M., Shankar G.M., Walsh D.M. Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases. Mol. Med. 2008; 14: 451–464.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>30. Luheshi L.V., Dobson C.M. Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett. 2009: 583: 2581–2586.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>31. Nakazato M., Matsukura S. New Type of Amyloidosis b) Islet Amyloid Polypeptide (IAPP/Amylin) in non-insulin dependent diabetes mellitus. Int. Med. 1993; 32 (12): 928–929.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>32. Watts J.C., Condello C., Stöhr J., Oehler A., Lee J., De Armond S.J., Lannfelt L., Ingelsson M., Giles K., Prusiner S.B. Serial propagation of distinct strains of A β prions from Alzheimer’s disease patients. Proc. Natl. Acad. Sci. USA. 2014; 111 (28): 10323–10328.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>33. Chernoff Y.O. Protein heredity and evolution. In: Charles Darwin and modern biology. E’.I. Kolchinskii, A.A. Fedotova (eds.). St. Petersburg: Nestor-Istoriia. 2010. P. 76–94.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>34. Kim J.I., Cali I., Surewicz K., Kong Q., Raymond G.J., Atarashi R., Race B., Qing L., Gambetti P., Caughey B., Surewicz W.K. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 2010;285: 14083–14087.</mixed-citation></ref></ref-list></back></article>
